METHYL 4-CHLORO-2-METHYL-5-NITROBENZOATE, 97.0%, 250mg

2-Bromo-3-methylbenzotrifluoride, 98.0%, 1g

5-(4-Isopropylphenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 250mg

(3S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid hydrochloride, 95.0%, 5g

(S)-Methyl 3-amino-3-(4-chlorophenyl)propanoate, 95.0%, 250mg

2-(1H-Indol-1-yl)ethanol, 97%, 100mg

2-Hydroxy-3-phenylpropanoic acid, 98.0%, 5g

4,5,6,7-Tetrahydro-benzo[ d ]isoxazole-3-carboxylic acid, 95.0%, 2.5g

3-Ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one, 97.0%, 100mg

2-ETHOXY-N-((1-(PIPERAZIN-1-YL)CYCLOHEXYL)METHYL)BENZAMIDE, 93.0%, 1g

HPLC column NUCLEODUR® NH2-RP 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide, 98%, 1g

2-Chloro-5-methoxypyridine, 95.0%, 5g